These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7626164)

  • 1. Analgesic, antimuscarinic activity and enantioselectivity of the four isomers of 3-quinuclidinyl tropate as compared with the enantiomers of hyoscyamine.
    Dei S; Bellucci C; Gualtieri F; Romanelli MN; Scapecchi S; Teodori E; Bartolini A; Ghelardini C
    Farmaco; 1995 May; 50(5):303-9. PubMed ID: 7626164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic activity and selectivity for opioid receptors of enantiomers of ohmefentanyl.
    Jin WQ; Wang ZX; Chen J; Chen XJ; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):421-4. PubMed ID: 9863164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization and pharmacological profile of tropicamide enantiomers.
    Dei S; Bellucci C; Ghelardini C; Romanelli MN; Spampinato S
    Life Sci; 1996; 58(23):2147-53. PubMed ID: 8649199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization of a novel, potent and selective M3 antagonist.
    Ghelardini C; Bartolini A; Galeotti N; Bellucci C; Dei S; Gualtieri F
    Life Sci; 1997; 61(13):1217-26. PubMed ID: 9324063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective antimuscarinic effects of 3-quinuclidinyl atrolactate and 3-quinuclidinyl xanthene-9-carboxylate.
    Noronha-Blob L; Sturm B; Lowe V
    Eur J Pharmacol; 1992 Jan; 211(1):97-103. PubMed ID: 1618272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aliphatic and heterocyclic analogues of arecaidine propargyl ester. Structure-activity relationships of mono- and bivalent ligands at muscarinic M1 (M4), M2 and M3 receptor subtypes.
    Moser U; Gubitz C; Galvan M; Immel-Sehr A; Lambrecht G; Mutshcler E
    Arzneimittelforschung; 1995 Apr; 45(4):449-55. PubMed ID: 7779140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive profile of 3-alpha-tropanyl 2-(4-Cl-phenoxy)butyrate (SM-21) [corrected]: a novel analgesic with a presynaptic cholinergic mechanism of action.
    Ghelardini C; Galeotti N; Gualtieri F; Bellucci C; Manetti D; Giotti A; Malmberg-Aiello P; Galli A; Bartolini A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):430-9. PubMed ID: 9223584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoisomers of N-substituted soft anticholinergics and their zwitterionic metabolite based on glycopyrrolate--syntheses and pharmacological evaluations.
    Wu WM; Wu J; Mori N; Buchwald P; Bodor N
    Pharmazie; 2008 Mar; 63(3):200-9. PubMed ID: 18444508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptolepis sanguinolenta: antimuscarinic properties of cryptolepine and the alkaloid fraction at M1, M2 and M3 receptors.
    Rauwald HW; Kober M; Mutschler E; Lambrecht G
    Planta Med; 1992 Dec; 58(6):486-8. PubMed ID: 1484884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological activity and receptor-binding characteristics of 2 beta-(2'-phenyl-2'-cyclopentyl-2'-hydroxy-ethoxy)tropane and its optical isomers.
    Gao ZG; Cui WY; Wang L; Liu CG
    Arch Int Pharmacodyn Ther; 1996; 331(2):124-35. PubMed ID: 8937624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic activity and receptor binding of the enantiomers of aceclidine and its methiodide.
    Ringdahl B; Ehler FJ; Jenden DJ
    Mol Pharmacol; 1982 May; 21(3):594-9. PubMed ID: 6125875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.
    Scapecchi S; Nesi M; Matucci R; Bellucci C; Buccioni M; Dei S; Guandalini L; Manetti D; Martelli C; Martini E; Marucci G; Orlandi F; Romanelli MN; Teodori E; Cirilli R
    J Med Chem; 2010 Jan; 53(1):201-7. PubMed ID: 19928767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
    Sheardown MJ; Shannon HE; Swedberg MD; Suzdak PD; Bymaster FP; Olesen PH; Mitch CH; Ward JS; Sauerberg P
    J Pharmacol Exp Ther; 1997 May; 281(2):868-75. PubMed ID: 9152396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-(2-Benzofuranyl)quinuclidin-2-ene derivatives: novel muscarinic antagonists.
    Nordvall G; Sundquist S; Johansson G; Glas G; Nilvebrant L; Hacksell U
    J Med Chem; 1996 Aug; 39(17):3269-77. PubMed ID: 8765510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
    Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C
    J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol.
    Varoli L; Angeli P; Buccioni M; Burnelli S; Cavalli A; Marucci G; Recanatini M
    Farmaco; 2003 Sep; 58(9):651-7. PubMed ID: 13679157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.
    Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Martini E; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
    J Med Chem; 2007 Mar; 50(6):1409-13. PubMed ID: 17305327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoisomers of 3-(2,3-dihydrobenzofuran-2-yl)quinuclidine: preparation and muscarinic receptor affinities.
    Johansson G; Brisander M; Sundquist S; Hacksell U
    Chirality; 1998; 10(9):813-20. PubMed ID: 9839431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antimuscarinic activity of some ether- and thioether-bearing 1,3-dioxolanes and related sulfoxides and sulfones.
    Malmusi L; Franchini S; Mucci A; Schenetti L; Gulini U; Marucci G; Brasili L
    Bioorg Med Chem; 1998 Jun; 6(6):825-32. PubMed ID: 9681148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery & development of selective M3 antagonists for clinical use.
    Alabaster VA
    Life Sci; 1997; 60(13-14):1053-60. PubMed ID: 9121347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.